Skip to content

The study on the effects on atherosclerotic diseases by periodontal treatment

The study on the effects on atherosclerotic diseases by periodontal treatment - Relation between atherosclerotic diseases and periodontitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008071
Enrollment
150
Registered
2012-06-01
Start date
2012-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Atherosclerosis

Interventions

None listed

Sponsors

Okayama University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with lifestyle-related disease: one of following criteria LDL over 140 mg/dl systolic blood pressure over 140 mmHg diastolic blood pressure over 90mmHg fasting blood glucose over 110 mg/dl glycosylated Hemoglobin A over 5.9 % Periodontitis patients:following criteria periodontal probing depth over 4mm at any probing site

Exclusion criteria

Exclusion criteria: A) acute myocardial infarction (within 6 months) B) unstable angina C) severe heart diseases D) Cardiovascular surgery (within 6 months) E) cerebrovascular accidents (within 6 months) F) severe hepatitis or renal disease G) malignant tumors H) port control diabetes I) lipidosis with following conditions a) nephrotic syndrome b) hypothyroidism c) cushing Syndrome d) secondary hyperlipemia according to other diseases J) hyperlipemia according to medicine such as steroids K) perioperative patients L) patients with poor compliance

Design outcomes

Primary

MeasureTime frame
Periodontitis: Periodontal probing depth, Blood IgG antibody titer to periodontal pathogens Atherosclerosis: Carotid artery Intima - media thickness, Serum lipid, Blood sugar

Secondary

MeasureTime frame
Body Mass Index, Creatine phosphokinase, White blood cell, Urine occult blood, Pulse wave velocity, High - sensitivity C - reactive protein, Tumor necrosis factor - alpha, Adiponectin

Countries

Japan

Contacts

Public ContactShogo Takashiba

Okayama University Department of Pahophysiology - Periodontal Science, Graduate School of Medicine, Dentistry and Phar

perio@cc.okayama-u.ac.jp086-235-6675

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026